These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17413450)

  • 41. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder.
    Dorval KM; Wigg KG; Crosbie J; Tannock R; Kennedy JL; Ickowicz A; Pathare T; Malone M; Schachar R; Barr CL
    Genes Brain Behav; 2007 Jul; 6(5):444-52. PubMed ID: 17010153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of ADRA2A and BDNF gene-gene interaction on the continuous performance test phenotype.
    Cho SC; Kim JW; Kim HW; Kim BN; Shin MS; Cho DY; Jung SW; Chung US; Son JW
    Psychiatr Genet; 2011 Jun; 21(3):132-5. PubMed ID: 21063237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No association between dopaminergic polymorphisms and intelligence variability in attention-deficit/hyperactivity disorder.
    Genro JP; Roman T; Zeni CP; Grevet EH; Schmitz M; de Abreu PB; Bau CH; Rohde LA; Hutz MH
    Mol Psychiatry; 2006 Dec; 11(12):1066-7. PubMed ID: 17130883
    [No Abstract]   [Full Text] [Related]  

  • 44. Neuroendocrine aspects of attention deficit hyperactivity disorder.
    Jensen JB; Garfinkel BD
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):111-29. PubMed ID: 2897907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder.
    Barr CL; Feng Y; Wigg K; Bloom S; Roberts W; Malone M; Schachar R; Tannock R; Kennedy JL
    Mol Psychiatry; 2000 Jul; 5(4):405-9. PubMed ID: 10889551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No preferential transmission of paternal alleles at risk genes in attention-deficit hyperactivity disorder.
    Laurin N; Feng Y; Ickowicz A; Pathare T; Malone M; Tannock R; Schachar R; Kennedy JL; Barr CL
    Mol Psychiatry; 2007 Mar; 12(3):226-9. PubMed ID: 17325714
    [No Abstract]   [Full Text] [Related]  

  • 47. Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C.
    Barr CL; Wigg K; Zai G; Roberts W; Malone M; Schachar R; Tannock R; Kennedy JL
    Mol Psychiatry; 2001 May; 6(3):334-7. PubMed ID: 11326305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A rare polymorphism affects a mitogen-activated protein kinase site in synapsin III: possible relationship to schizophrenia.
    Porton B; Ferreira A; DeLisi LE; Kao HT
    Biol Psychiatry; 2004 Jan; 55(2):118-25. PubMed ID: 14732590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder.
    Roman T; Polanczyk GV; Zeni C; Genro JP; Rohde LA; Hutz MH
    Mol Psychiatry; 2006 Jan; 11(1):8-10. PubMed ID: 16172611
    [No Abstract]   [Full Text] [Related]  

  • 50. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?
    Zametkin AJ; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1987 Sep; 26(5):676-86. PubMed ID: 2889717
    [No Abstract]   [Full Text] [Related]  

  • 51. Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients.
    Ponce G; Hoenicka J; Rubio G; Ampuero I; Jiménez-Arriero MA; Rodríguez-Jiménez R; Palomo T; Ramos JA
    Mol Psychiatry; 2003 May; 8(5):466-7. PubMed ID: 12808424
    [No Abstract]   [Full Text] [Related]  

  • 52. Mutational analysis of the synapsin III gene on chromosome 22q12-q13 in schizophrenia.
    Ohtsuki T; Ichiki R; Toru M; Arinami T
    Psychiatry Res; 2000 Apr; 94(1):1-7. PubMed ID: 10788672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutation analysis of synapsin III gene in schizophrenia.
    Tsai MT; Hung CC; Tsai CY; Liu MY; Su YC; Chen YH; Hsiao KJ; Chen CH
    Am J Med Genet; 2002 Jan; 114(1):79-83. PubMed ID: 11840510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphisms in the promoter and coding regions of the synapsin III gene. A lack of association with schizophrenia.
    Imai K; Harada S; Kawanishi Y; Tachikawa H; Okubo T; Suzuki T
    Neuropsychobiology; 2001; 43(4):237-41. PubMed ID: 11340362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The genetics of attention-deficit/hyperactivity disorder.
    Pauls DL
    Biol Psychiatry; 2005 Jun; 57(11):1310-2. PubMed ID: 15950003
    [No Abstract]   [Full Text] [Related]  

  • 56. Synapsin III gene polymorphisms and schizophrenia.
    Ohmori O; Shinkai T; Hori H; Kojima H; Nakamura J
    Neurosci Lett; 2000 Jan; 279(2):125-7. PubMed ID: 10674637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Attention deficit hyperactivity disorder: interpretation of a recent genetic study].
    Gonon F; Cohen D
    Med Sci (Paris); 2011 Mar; 27(3):315-7. PubMed ID: 21447307
    [No Abstract]   [Full Text] [Related]  

  • 58. Attention deficit hyperactivity disorder in a multigenerational pedigree.
    Faraone SV; Biederman J; Mick E; Wozniak J; Kiely K; Guite J; Ablon JS; Warburton R; Reed E
    Biol Psychiatry; 1996 May; 39(10):906-8. PubMed ID: 8860195
    [No Abstract]   [Full Text] [Related]  

  • 59. [What role do genetic factors play in the etiology of minimal brain dysfunction?].
    Kalbe U
    Offentl Gesundheitswes; 1984 Mar; 46(3):122-4. PubMed ID: 6232479
    [No Abstract]   [Full Text] [Related]  

  • 60. Pathophysiology of ADDH.
    Shekim WO
    J Am Acad Child Adolesc Psychiatry; 1988 May; 27(3):389-90. PubMed ID: 2897958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.